| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Apr 24, 2026 | Oncology Ventures: $62 Million Fund II Closes Oversubscribed, Nearly Double The Size Of Fund I | Oncology Ventures, an Austin, Texas-based venture capital firm investing in commercially validated startups transforming cancer care, has announced the close of an oversubscribed $62 million Fund II, nearly double the size of its $32 millio... |
| Feb 19, 2026 | Vie Ventures Names Jeff Bluestone, PhD, As Managing Director | Vie Ventures, a life sciences venture capital firm focused on autoimmune and immune-mediated diseases, announced that Jeff Bluestone, PhD, has been named Managing Director. He joins founders Steven St. Peter, MD, and Luke Evnin, PhD, who al... |
| Oct 13, 2025 | The Science Center Returns to HLTH USA with Expanded Pavilion and Global Focus, Announces U.S. Market Access Program Expansion | The Philadelphia-based institution is looking to engage with startup leaders, investors, healthcare providers, and other innovators from across the healthcare industry.
PHILADELPHIA, Oct. 13, 2025 /PRNewswire-PRWeb/ -- The Science Center wi... |
| Jul 29, 2025 | Society for Immunotherapy of Cancer Announces 2025 Annual Award Recipients | Society for Immunotherapy of Cancer
The Society for Immunotherapy of Cancer (SITC) is proud to recognize individuals who have made outstanding contributions to the field of immuno-oncology. SITC is pleased to announce the recipients of its ... |
| Jul 24, 2025 | Dispatch Bio Raises Series A in Funding; Total To $216M | Dispatch Bio, a San Francisco, CA- and Philadelphia, PA-based Biotechnology company developing treatments for tumours, raised an undisclosed amounting Series A funding.
Backers included ARCH Venture Partners and PICI, along with Bristol Mye... |
| Jun 18, 2025 | CEO of Sean Parker’s breakthrough cancer drug institute on leading new race for cure | As the first female CEO at the more than century-old American Cancer Society, and first CEO to come from oncology research, Karen Knudsen oversaw a 30% rise in revenue.
She recently assumed the CEO post at the Parker Institute for Cancer Im... |
| May 13, 2025 | SITC Announces Keynote Speakers Dr. Jennifer Wargo and Dr. Ira Mellman at its 40th Anniversary Annual Meeting | SITC 40th Anniversary Annual Meeting & Pre-Conference Programs logo
Celebrating 40 Years of Driving Breakthroughs in Cancer Immunotherapy The Society for Immunotherapy of Cancer (SITC) is proud to announce Jennifer A. Wargo, MD, MMSc, f... |
| Sep 9, 2024 | Стартап в сфере клеточной терапии ArsenalBio привлек $325 млн | В раунде финансирования Arsenal Biosciences приняли участие новые инвесторы ARCH Venture Partners, Milky Way Investments Group, Regeneron Ventures, NVentures (венчурное подразделение NVIDIA), Luma Group, фонды, консультируемые T. Rowe Price... |
| Sep 4, 2024 | ArsenalBio: $325 Million (Series C) To Enhance Programmable Cell Therapy Programs | Arsenal Biosciences, a clinical-stage programmable cell therapy company focused on engineering advanced CAR T-cell therapies for solid tumors, announced today the closing of an oversubscribed $325 million Series C financing round.
This fund... |
| Sep 4, 2024 | ArsenalBio Raises $325M in Series C Funding | ArsenalBio, a San Francisco, CA-based clinical stage programmable cell therapy company, raised $325M in Series C funding.
The round was led by ARCH Venture Partners, Milky Way Investments Group, Regeneron Ventures, NVentures, Luma Group, fu... |
| Dec 7, 2023 | The tech billionaires trying to hack longevity and live forever | From Sam Altman (from top left, clockwise) to Peter Thiel, Mark Zuckerberg, Jeff Bezos, and Sergey Brin, many of the world's wealthiest billionaires seem to be on a quest for the fountain of youth. Lucy Nicholson/Reuters/Marco Bello/Getty I... |
| Jan 29, 2023 | From Jeff Bezos to Jack Dorsey, here are 14 the world's wealthiest entrepreneurs trying to crack the code of living forever | Jeff Bezos is one among a handful of billionaires working to rewind the clock. Gareth Cattermole / Staff/ Getty Images
A growing number of the world's richest entrepreneurs are using their wealth to fight aging.
They're taking supplements, ... |
| Sep 29, 2022 | Gladstone Institutes Joins the Parker Institute for Cancer Immunotherapy Network | The new research center will accelerate cures for the world's gravest cancers
SAN FRANCISCO, Sept. 28, 2022 /PRNewswire/ -- Gladstone Institutes has partnered with the Parker Institute for Cancer Immunotherapy (PICI), the leading network of... |
| Oct 5, 2021 | Победа над раком с помощью информационных технологий | В этой статье мы изложим новую, пока ещё фантастическую, идею о том как с помощью информационных технологий можно победить рак. Быть может, полностью. Мир без рака возможен. В некой перспективе, близость которой зависит от нас.
Это лонгрид.... |
| Oct 9, 2020 | An Initiative Led by Parker Institute for Cancer Immunotherapy and Cancer Research Institute Discovers Keys That Could Unlock Better Personalized Treatments to Destroy Cancer | |
| Jul 31, 2020 | Tetraphase deal done, La Jolla Pharmaceutical taps Larry Edwards as CEO; Longtime Eli Lilly exec Michael Overdorf heads to Annexon as CBO | Larry Edwards
→ As La Jolla Pharmaceutical closed on their acquisition of Tetraphase on Wednesday, the San Diego biotech also announced that they’re taking the president and CEO right along with them as Larry Edwards steps... |
| Apr 9, 2020 | Frederic Pla enlisted as COO at the Parker Institute; Former Alkermes exec named CMO at Seres Therapeutics | Frederic Pla Parker Institute
→ The Parker Institute for Cancer Immunotherapy has welcomed Frederic Pla aboard as COO. Prior to his appointment, Pla served as COO at Genomic Health. Pla has held appointments at Life Te... |
| Jan 14, 2020 | Innovation in biotech R&D: New resources offer new hope | Link to full Op Ed on STAT NEWS
Public optimism about American health care seems in short supply if you read the news, which is dominated by coverage of partisan fights over the Affordable Care Act and the continuing crisis of opioid addic... |
| Jan 14, 2020 | Innovation in biotech R&D: New resources offer new hope | Public optimism about American health care seems in short supply if you read the news, which is dominated by coverage of partisan fights over the Affordable Care Act and the continuing crisis of opioid addiction. But innovation in the life ... |
| Oct 17, 2019 | ArsenalBio emerges from stealth with $85 million and a dream team to fight cancer | The story behind ArsenalBio begins with Sean Parker’s Institute for Cancer Immunotherapy.
Founded in 2016, the Institute has been instrumental in providing a space for the top researchers into cancer across different fields to collaborate a... |
| Jul 9, 2019 | The Parker Institute looks to grow, leveraging outside donors and equity stakes | LOS ANGELES — Internet billionaire Sean Parker has spent hundreds of millions of dollars of his fortune — and almost entirely his fortune alone — in an effort to build a new model for developing treatments that harness the immune system to ... |
| Jul 9, 2019 | Billionaire Sean Parker is nerding out on cancer research. Science has never seen anyone quite like him | Soon after cancer immunotherapy pioneer Jim Allison won the Nobel Prize in medicine last October, his billionaire benefactor Sean Parker called with a cryptic message: Someone would need to be home on Friday afternoon. A delivery was coming... |
| May 29, 2019 | Novartis backs $30M round for cancer biotech; Bayer drug makes a ‘breakthrough’ at FDA | → Ayala Therapeutics — which focuses on rare cancers that occur due to dysregulation of the Notch-activating pathway — has raised $30 million in a round of financing led by partner Novartis.
The funds, which also came... |
| Aug 13, 2018 | Using CRISPR for the ‘smaller wins,’ like making chemotherapy less toxic | Although the phrase “war on cancer” was first uttered in 1971, the breakthroughs in biomedical research that have emerged during this decade have supercharged the fight. The introduction of CRISPR-Cas9 — the molecular scissors that can edit... |
| Feb 25, 2018 | Inside The Exclusive Event Disrupting The Future Of Tech | Sean Parker (L) and will.i.am speak onstage at will.i.am's i.am.angel Foundation TRANS4M 2018 Gala,... [+] Honoring Sean Parker, tech entrepreneur, investor and Chairman, Parker Institute for Cancer Immunotherapy at Milk Studios in Hollywoo... |
| Jan 4, 2018 | David Beier Op-Ed: The NIH is in danger of losing its edge in creating biomedical innovations | Article in Stat News
In Ernest Hemingway’s “The Snows of Kilimanjaro,” the protagonist dies from an infection after scratching his leg on a thorn. That was in 1936, before the introduction of penicillin. It’s hard to imagine a world in whi... |
| Jan 3, 2018 | The NIH is in danger of losing its edge in creating biomedical innovations | In Ernest Hemingway’s “The Snows of Kilimanjaro,” the protagonist dies from an infection after scratching his leg on a thorn. That was in 1936, before the introduction of penicillin. It’s hard to imagine a world in which every cut had the p... |
| Nov 14, 2017 | Parker Institute, MD Anderson and Seres developing a microbiome/PD-1/L1 combo; CRISPR-Cas antimicrobial biotech Locus raises $17M | → Just days ago, MD Anderson researcher Jennifer Wargo and colleagues published new research that showed how the gut microbiome played a big role in determining whether or not a checkpoint therapy could help save your life.... |
| Oct 9, 2017 | Adage Capital Leads $8M Funding for ImaginAb | ImaginAb, an immuno-oncology imaging company, has raised an additional $8 million in new equity funding led by Adage Capital. The company's shareholders also include the Parker Institute for Cancer Immunotherapy, NVF, Cycad Group, Nextech I... |
| Oct 9, 2017 | Adage Capital Leads $8M Funding for ImaginAb | ImaginAb, an immuno-oncology imaging company, has raised an additional $8 million in new equity funding led by Adage Capital. The company's shareholders also include the Parker Institute for Cancer Immunotherapy, NVF, Cycad Group, Nextech I... |
| Oct 5, 2017 | Report: Sean Parker and Peter Thiel back cancer immunotherapy startup 3T Biosciences | The Parker Institute spans six centers with more than 63 labs and numerous researchers and industry and nonprofit partners. The Institute also pools and shares its resources.
There are 240 cancer immunotherapies under development, according... |
| Apr 25, 2017 | The Broad Institute is testing the limits of what ‘nonprofit’ means | When a federal patent court ruled that the nonprofit Broad Institute of MIT and Harvard could legally license its version of the CRISPR-Cas9 genome-editing system, it opened the door to millions of dollars of revenue for the institute. It a... |
| Dec 1, 2016 | Sean Parker is partnering with the Cancer Research Institute to find a cancer vaccine | Cancerous tumors carry certain markers called neoantigens and Facebook billionaire Sean Parker wants to use algorithms to find them.
To do so, the Parker Institute for Cancer Immunotherapy will work with more than 30 public and private phar... |
| Report: Sean Parker and Peter Thiel back cancer immunotherapy startup 3T Biosciences | One year after setting up a $250 million institute devoted to cancer immunotherapy, Sean Parker has backed 3T Biosciences alongside fellow billionaire investor Peter Thiel. Both were part of a $12 million + funding round for the stealth imm... |
